Abstract Surgery of parathyroid revolves around the management of hyperparathyroidism (HPT). In most cases, occurrence is sporadic rather than familial, and 80-85% of cases of sporadic primary HPT are caused by a solitary parathyroid adenoma. The diagnosis is made by hypercalcaemia with an inappropriately elevated parathyroid hormone (PTH) level and a 24-hour urine calcium excretion level that is normal or high. Improved assay for PTH has led to earlier detection of HPT and has been responsible for the apparent increase in the prevalence of the disorder. An improvement in preoperative localisation studies as well as the development of a rapid intraoperative PTH assay has changed the approach to parathyroid surgery in the last two decades. This article provides a brief overview of management of primary HPT.
The parathyroid glands were fi rst identifi ed in 1850 in an Indian Rhinoceros in a London zoo by Richard Owen, then Professor of Anatomy at the Hunterian Museum of the Royal College of Surgeons of England [1] . His work published in 1862 went unnoticed for several years. Credit for the recognition of the parathyroid glands in humans went to Ivar Sandstrom a medical student at Uppsala University in Sweden who named them "glandulae parathyroidae". The fi rst parathyroidectomy for primary HPT was performed by Mandl in 1925 [2] .
Surgical anatomy and physiological aspects
A thorough understanding of the anatomy of parathyroid glands is essential before embarking on parathyroid exploration. The parathyroid glands usually four in number arise from the endoderm of the third and fourth pharyngeal pouches. The superior parathyroids arise from the fourth pharyngeal pouch and are usually present superior to the inferior thyroid artery and dorsal to the recurrent laryngeal nerve. The inferior parathyroid glands arise from the third pharyngeal pouch and descend with the thymus into the lower part of the neck [3] . Due to this longer migration, they may be found at any position in the neck and the mediastinum, although the majority lie within 1-2 cm of the lower pole of the thyroid gland. The inferior parathyroids usually lie inferior to the inferior thyroid artery and ventral to the recurrent laryngeal nerve. Although most people have four parathyroid glands, a range from 2 to 6 have been described.
Parathyroid hormone (PTH) is an intact 84 amino acid peptide with amino and carboxyl terminals that is secreted in response to a fall in plasma ionised calcium concentration. The circulating PTH which has a half-life of REVIEW ARTICLE about 5 minutes in patients with normal renal function, is initially cleaved in the liver, yielding an inactive C-terminal fragment, which is ultimately cleared by the kidney [4] . The N-terminal fragment is the part of the peptide that is responsible for the biological activity of PTH on peripheral tissues. PTH interacts with vitamin D and its metabolites in regulating calcium absorption and secretion. PTH has direct effects that promote reabsorption of calcium from renal tubules and bone. PTH has indirect effects, mediated by increasing renal conversion of 25-hydroxycholecaciferol to more potent hormone 1,25 dihydroxycholecalciferol which results in increased calcium absorption from food.
The surgery of parathyroids revolves around the management of primary HPT and hence the management of primary HPT is discussed in detail below.
Primary hyperparathyroidism
Primary HPT is the detection of hypercalcaemia in the presence of inappropriately elevated circulating PTH levels. Primary HPT is the most common cause of hypercalcaemia in unselected non-hospitalised patients. It is the second most common cause of hypercalcaemia (after malignancy) in hospitalised patients.
The exact cause of sporadic primary HPT is unknown and is likely multifactorial, with environmental and genetic causes. It is associated with a history of radiation exposure [5, 6] as well as with prolonged lithium use [7, 8] . Genetic associations in sporadic primary HPT include over expression of the PRAD1 oncogene (encoding cyclin D1) and an inactivating mutation of the multiple endocrine neoplasia type 1 (MEN1) tumour-suppressor gene (encoding menin) [9] . The MEN1 gene is also associated with familial HPT, as are RET (associated with MEN2), HRPT2 (encoding parafi bromin, associated with HPT-jaw tumour syndrome), and the CASR gene (encoding the calcium-sensing receptor, associated with neonatal primary HPT).
Incidence
There is, however, a higher prevalence with increasing age, especially in females. In the age group below 40, the incidence of HPT is about 10 cases per 100,000 populations. In those over the age of 60 years, there is a steep rise in incidence to about 91/100,000 in men and 188/100,000 in women. The incidence is highest in the third to fi fth decade.
Pathology
Primary HPT may be sporadic or familial. In most cases (80-85%), sporadic primary HPT is caused by a solitary parathyroid adenoma, with the remainder of cases due to double adenomas (about 4%), multiple-gland hyperplasia (10-15%) and parathyroid carcinoma (<1%). Familial syndromes associated with primary HPT include MEN1 and MEN2, non-MEN, familial HPT, HPT-jaw tumour syndrome, and familial neonatal HPT. These familial syndromes are associated with (usually asymmetric) multiple-gland hyperplasia. In addition, non-MEN familial HPT and HPT-jaw tumour syndrome are associated with an increased risk of parathyroid cancer.
Hyperplasia of all four parathyroids is typical of secondary HPT. However, hyperplasia is responsible for the primary disease in about 10% of cases and may affect two or more glands. The chief cells are frequently involved. In contrast to an adenomatous gland, the hyperplastic parathyroid shows no rim of normal tissue and the overall appearance is uniform. Nodular hyperplasia is a feature strongly associated with MEN syndrome.
Carcinoma parathyroid is a rare cause of HPT accounting for <2% of all cases of primary HPT. Most cases occur in the fourth to sixth decade of life and in contrast to the female predominance observed for adenomas, there are no sex differences in the incidence of carcinomas [10] . A visible and palpable lump in the thyroid region along with hypercalcaemia should alert the surgeon to the possibility of diagnosis of carcinoma of the parathyroid. The defi nitive diagnosis is only made postoperatively from histopathology. Typically, the carcinoma is fi rm to hard, grey in colour and adherent to the adjacent tissue. The distant metastases to the liver and bone is a late feature and indicate terminal disease. 
